# Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

> **NCT04975438** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 34 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DRUG:** GSK1070806
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04975438
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-18
- **Primary completion:** 2022-12-19
- **Final completion:** 2023-03-13
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04975438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04975438, "Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT04975438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*